RT @FarmaciaOesteAP: (JAMA)Recomendaciones de uso de estatinas en prevención 1ª de USPSTF https://t.co/LQ8qS9f6Qj y la evidencia revisada h…
RT @vmontori: This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp h…
RT @FarmaciaOesteAP: (JAMA)Recomendaciones de uso de estatinas en prevención 1ª de USPSTF https://t.co/LQ8qS9f6Qj y la evidencia revisada h…
Actualizaciones con las estatinas. https://t.co/tq3jPXnljs
(JAMA)Recomendaciones de uso de estatinas en prevención 1ª de USPSTF https://t.co/LQ8qS9f6Qj y la evidencia revisada https://t.co/TqBMFbobqD
JAMA: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults https://t.co/pwIuUnvw3r
JAMA: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults https://t.co/t0f9E0urHW
JAMA: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults https://t.co/10Vv030VVv
JAMA: Statin Use for the Primary Prevention of Cardiovascular Disease in Adults https://t.co/7920Px1ZQM
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @vmontori: This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp h…
RT @vmontori: This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp h…
Estatinas en prevención primaria. Nueva GPC (USPSTF) https://t.co/lgcjFrqGMQ editorial https://t.co/bcKi0X8i4e video https://t.co/aktkgfAdOB
RT @JACastilloMo: Current evidence is insufficient to assess the balance of benefits and harms of statin use for the primary prevention in…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @vmontori: This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp h…
(JAMA) Recomendaciones USPSTF x el uso de estatinas en prevenc 1ª https://t.co/1Ue2UG193p Rev Sist en las q se basa https://t.co/DSHNKbbOfj
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
#Statin Use for Primary #Prevention of #Cardiovascular #Disease in Adults https://t.co/ExR83g0WUu
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @vmontori: This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp h…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @SVHTA: Statin Use for Primary Prevention of Cardiovascular Disease in Adults https://t.co/QF1fMejJrL
RT @vic_pallares: Statin Use for the Primary Prevention of CVD in Adults USPSTFRS. https://t.co/Eu3joxVvqS @Mitotatu @SergioCinza @dreyald…
RT @vmontori: This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp h…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/w3OnUdjao9 https://t.co/jClXdKgeCT
RT @JAMA_current: USPSTF #statin use for #primaryprevention of #cardiovasculardisease in adults https://t.co/B6ulaZNgM2
Only 2/100 people treated will benefit. 98-100 get NO benefit. 5 to 20/100 will experience serious adverse effects. Are you feeling lucky? https://t.co/AXZclqF68Y
RT @tweetmedico: Uso de estatinas como prevención primaria en adultos de 40 a 75 años con factores de riesgos cardiovasculares https://t.co…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @AlanaziZaid: Statin Use for Primary Prevention of Cardiovascular Disease in Adults https://t.co/iYUqRNxQOq
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @vmontori: This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp h…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @JAMA_current: USPSTF #statin use for #primaryprevention of #cardiovasculardisease in adults https://t.co/B6ulaZNgM2
And,there is no research ever on natural #cholesterol reducers like #astaxanthin(as there is no money to b made). https://t.co/7f26kIgwC8
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @tweetmedico: Uso de estatinas como prevención primaria en adultos de 40 a 75 años con factores de riesgos cardiovasculares https://t.co…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
スタチンは心血管疾患の一次予防に有効か? 外来でこんなややこしい話されて、患者さんにわかってもらえるのかな? https://t.co/1oAw0BidqZ https://t.co/mbYlt7sXm1
RT @tweetmedico: Uso de estatinas como prevención primaria en adultos de 40 a 75 años con factores de riesgos cardiovasculares https://t.co…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @tweetmedico: Uso de estatinas como prevención primaria en adultos de 40 a 75 años con factores de riesgos cardiovasculares https://t.co…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @tweetmedico: Uso de estatinas como prevención primaria en adultos de 40 a 75 años con factores de riesgos cardiovasculares https://t.co…
RT @vmontori: This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp h…
RT @tweetmedico: Uso de estatinas como prevención primaria en adultos de 40 a 75 años con factores de riesgos cardiovasculares https://t.co…
RT @doctormacias: La Naturaleza no tiene un plan para los mayores de 40 años. Muchos debieran tomar estatinas (V.gr: atorvastatina) https:/…
RT @doctormacias: La Naturaleza no tiene un plan para los mayores de 40 años. Muchos debieran tomar estatinas (V.gr: atorvastatina) https:/…
RT @tweetmedico: Uso de estatinas como prevención primaria en adultos de 40 a 75 años con factores de riesgos cardiovasculares https://t.co…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @vmontori: This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp h…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @vmontori: This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp h…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @vmontori: This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp h…
RT @vmontori: This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp h…
This is the guideline to care for these patients; this is the tool to care for a patient like these https://t.co/nPnaR9IQFp https://t.co/6uS7bvxE4H
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
#Statin Use for Primary #Prevention of #Cardiovascular #Disease in Adults https://t.co/1Yld2zLw24
Statin Use for Primary Prevention of Cardiovascular Disease in Adults https://t.co/4cmeTlOb0X
Uso de estatinas como prevención primaria en adultos de 40 a 75 años con factores de riesgos cardiovasculares https://t.co/DHp3tE7bxH
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
#hcsmeufr Statin Use for Primary Prevention of Cardiovascular Disease in Adults… https://t.co/lYDRHX0rhy, see more https://t.co/G05ctxUUW3
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
Important #statins discussion on #primary #prevention and (lack of) #evidence. #aha16 #cvd @EricTopol @JAMA_current https://t.co/j8xINc0l8q
New STATIN guideline... https://t.co/fmnTmKtjPc
RT @JAMA_current: USPSTF #statin use for #primaryprevention of #cardiovasculardisease in adults https://t.co/B6ulaZNgM2
RT @GoodroeJoane: The economics of making money on drugs influences the recommendations of when to use #without adequate evidence https://…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
RT @EricTopol: New statin guideline w/exuberant recommendations, w/o adequate evidence @JAMA_current #aha16 https://t.co/V2hpsq2UTk https:/…
#hcmktg EuroHealthNet Top story: Statin Use for Primary Prevention of Cardiovas… https://t.co/XpRF3YPzPJ, see more https://t.co/sEwF2Hkykf
#PharmaSuccess : Statin Use for Primary Prevention of Cardiovascular Disease in… https://t.co/pCLYwV4Icw, see more https://t.co/y0a8kS5MeC
Update on pros & cons of statin use for preventing cardiovascular events: https://t.co/lMD3q6dnFL #CVD #heartdisease